This Edition
ARTICLE | Clinical News
Ramelteon regulatory update
WIR Staff
September 27, 2004 7:00 AM UTC
Takeda submitted an NDA for ramelteon, an MT1 and MT2 receptor agonist, to treat insomnia. ...